Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
来自 14 个国家的多重耐药结核病患者队列的安全性和有效性结果，这些患者同时接受贝达喹啉、德拉马尼和其他二线药物治疗
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac176
Huerga, Helena; Khan, Uzma; Bastard, Mathieu; Mitnick, Carole D; Lachenal, Nathalie; Khan, Palwasha Y; Seung, Kwonjune J; Melikyan, Nara; Ahmed, Saman; Rich, Michael L; Varaine, Francis; Osso, Elna; Rashitov, Makhmujan; Salahuddin, Naseem; Salia, Gocha; Sánchez, Epifanio; Serobyan, Armine; Rafi Siddiqui, Muhammad; Grium Tefera, Dri; Vetushko, Dmitry; Yeghiazaryan, Lusine; Holtzman, David; Islam, Shirajul; Kumsa, Andargachew; Jacques Leblanc, Gamarly; Leonovich, Olga; Mamsa, Shahid; Manzur-Ul-Alam, Mohammad; Myint, Zaw; Padayachee, Shrivani; Franke, Molly F; Hewison, Catherine
